Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

by Tack, Cees J , Warren, Mark L , Jeppesen, Ole K , Mosenzon, Ofri , Husain, Mansoor , Donsmark, Morten , Dungan, Kathleen , Eliaschewitz, Freddy G , Thomsen, Mette , Bain, Stephen C , Pedersen, Sue D , Birkenfeld, Andreas L , Franco, Denise R , Vilsbøll, Tina , Lingvay, Ildiko

in Administration, Oral / Aged / Angina pectoris / Antidiabetics / Cardiovascular disease / Cardiovascular diseases / Cardiovascular Diseases - chemically induced / Cerebral infarction / Death / Diabetes / Diabetes mellitus / Diabetes mellitus (non-insulin dependent) / Diabetes Mellitus, Type 2 - complications / Diabetes Mellitus, Type 2 - drug therapy / Diabetic retinopathy / Double-Blind Method / Female / GLP-1 receptor agonists / Glucagon / Glucagon-like peptide 1 / Glucagon-Like Peptide-1 Receptor - agonists / Glucagon-Like Peptides - administration & dosage / Glucagon-Like Peptides - adverse effects / Glucose / Glycated Hemoglobin A - analysis / Heart attacks / Heart failure / Hospitalization / Humans / Hypoglycemic Agents - administration & dosage / Hypoglycemic Agents - adverse effects / Kidney diseases / Laboratories / Male / Middle Aged / Myocardial infarction / Peptides / Risk / Risk factors / Stroke / Veins & arteries

2019

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

2019

Confirm

Do you wish to request the book?

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

2019

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Tack, Cees J,

Warren, Mark L,

Jeppesen, Ole K,

Mosenzon, Ofri,

Husain, Mansoor,

Donsmark, Morten,

Dungan, Kathleen,

Eliaschewitz, Freddy G,

Thomsen, Mette,

Bain, Stephen C,

Pedersen, Sue D,

Birkenfeld, Andreas L,

Franco, Denise R,

Vilsbøll, Tina,

Lingvay, Ildiko

2019

Overview

Safety data exist for subcutaneous semaglutide, a glucagon-like peptide-1 receptor agonist, but not for the oral form. Here, oral semaglutide was assessed in a randomized, double-blind, placebo-controlled trial involving patients with type 2 diabetes at high cardiovascular risk; oral semaglutide was noninferior for cardiovascular safety.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Administration, Oral

/ Aged

/ Angina pectoris

/ Antidiabetics

/ Cardiovascular disease

/ Cardiovascular diseases

/ Cardiovascular Diseases - chemically induced